-
AstraZeneca IL-5R α monoclonal antibody approved for market in China
On August 19th, according to the official website of the National Medical Products Administration, AstraZeneca's IL-5R alpha monoclonal antibody (benralizumab) has been approved for listing in China. ... -
Approval of new indications for Mercado Pembrolizumab
On February 4th, Merck&Company announced that its PD-1 inhibitor pembrolizumab has been approved by the National Medical Products Administration (NMPA) of China for first-line treatment in combinatio ... -
AstraZeneca elontersen approved in the United States
On December 21st local time, AstraZeneca announced that its and Ionis company's eplontersen have been approved in the United States. Eplontersen is an antisense oligonucleotide (ASO) therapy for the ... -
Lilly diabetes drug is approved for adult weight loss in the United States, and its price is 20% cheaper than that of Pinot Noir and Nordisk
GLP-1 drugs have gained significant players in the field of weight loss, with prices 20% cheaper than Nuo and Nordsmiglutide. On November 8 local time, Eli Lilly, a multinational pharmaceutical giant ...